top of page

Quality Manager as a Service - Sites & Biotech

  • Paulo Cesar Fernandes
  • Aug 19, 2024
  • 3 min read

Clinical research is one of the most critical areas for the development of new treatments and medicines, playing a vital role in improving global public health. However, to ensure that the results are reliable and applicable, the quality of operations conducted in clinical research centers must be rigorously controlled and monitored.


This requirement is not just a matter of good practices, but a regulatory necessity imposed by agencies such as ANVISA, FDA, EMA and international guidelines such as the ICH/GCP (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - Good Clinical Practice) guidelines.





Regulatory Compliance: A Pillar for Quality


ANVISA - In Brazil, the National Health Surveillance Agency (ANVISA) has clear and rigorous guidelines for conducting clinical trials. These guidelines include Resolution RDC No. 9/2015 (which is currently undergoing development!!), which establishes standards for conducting clinical trials with drugs in the country. Compliance with these standards is crucial to ensure that the data generated is robust and accepted by regulatory authorities.


FDA - In the United States, the Food and Drug Administration (FDA) is responsible for ensuring that clinical trials follow rigorous quality and safety standards. Non-compliance can result in data rejection, delays in product development, and, in extreme cases, severe penalties.


EMA - In Europe, the European Medicines Agency (EMA) plays a similar role, setting guidelines that require all clinical trials to be conducted in accordance with good clinical practice (GCP). Compliance with these guidelines is essential for the approval of medicines on the European market.


ICH/GCP - The ICH/GCP guidelines provide an internationally recognized framework for the ethical and scientific conduct of clinical trials. They ensure that the rights, safety and well-being of study participants are protected and that the data generated are reliable and accurate.


The Need for Specialized Quality Management


Given the complexity and stringency of regulatory requirements, it is essential that clinical research centers maintain high quality standards throughout all phases of the study. However, many research centers, especially small and medium-sized ones, face challenges in implementing and maintaining an effective quality management system (QMS) that complies with all of these requirements.


It is in this context that the Quality Manager as a Service (QMaaS) offering emerges. This service offers a practical and specialized solution for clinical research centers that wish to ensure regulatory compliance and excellence in conducting clinical trials without the need to hire an in-house quality team.


QMaaS enables centers to:

  • Implement and maintain a robust, standards-compliant QMS : Under the guidance of quality experts who bring hands-on experience in ANVISA, FDA, EMA and ICH/GCP compliance.

  • Mitigate non-compliance risks : Ensuring that all stages of the study are conducted according to best practices and required standards, minimizing the risk of data rejection or penalties.

  • Increase operational efficiency : With standardized and auditable processes, which facilitate the rapid identification and resolution of deviations.

  • Have access to continuous and personalized consultancy : With professionals who understand the specific needs and challenges of the center, adapting quality solutions according to the size and particularities of each research project.


Conclusion


Quality in clinical research is not only a regulatory requirement, but a competitive differentiator that can determine the success or failure of a study. The Quality Manager as a Service (QMaaS) offering ensures that clinical research centers are not only compliant with the requirements of ANVISA, FDA, EMA and ICH/GCP, but also able to conduct studies with the highest quality and efficiency. With this solution, centers can focus on what they do best – conducting innovative research – while leaving quality management in the hands of experts.

Now is the time to prioritize quality and ensure that each study is conducted with the excellence necessary to positively impact global health.

Check out our Quality Manager as a Service solution!

 
 
 

Comments


bottom of page